Please assess the completion status of the following clinical trial:

Trial Title: Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children less than 18 years of age and at least 6 months post AVSD repair or reoperation~* At least moderate MR~* Asymptomatic or minimally symptomatic, defined by Ross Heart Failure Class I or II~* Atrioventricular synchrony (paced or intrinsic)~Exclusion Criteria:~* Tetrology of Fallot, total or partial anomalous venous connection~* More than trivial MS or outflow obstruction~* Other sources of LV volume overload~* Hypertrophic obstructive cardiomyopathy~* Significant residual coarctation

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): Ace inhibition (enalapril)

Based on this trial design, predict the completion outcome and termination type (if applicable).